NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $24.99 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Avanos Medical Stock (NYSE:AVNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avanos Medical alerts:Sign Up Key Stats Today's Range$24.99▼$24.9950-Day Range$24.99▼$25.0052-Week Range$9.30▼$25.49VolumeN/AAverage Volume700,357 shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company that develops and markets devices designed to improve patient care and support healthcare providers. Its products are used in areas including pain management, digestive health, and other procedural and specialty-care applications. The company’s portfolio includes the COOLIEF radiofrequency ablation system and ON-Q pain relief systems for non-opioid pain management, as well as MIC-KEY feeding tubes and the CORTRAK* 2 Enteral Access System for enteral nutrition and feeding-tube placement. Avanos sells its products to hospitals, healthcare professionals, and other care settings. Avanos was formed following the 2014 separation of Halyard Health from Kimberly-Clark and adopted the Avanos name in 2018. Based in Alpharetta, Georgia, the company serves healthcare markets internationally through a commercial presence spanning multiple geographic regions.AI Generated. May Contain Errors. Read More Avanos Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks2nd Percentile Overall ScoreAVNS MarketRank™: Avanos Medical scored higher than 2% of companies evaluated by MarketBeat, and ranked 895th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingAvanos Medical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAvanos Medical has only been the subject of 1 research reports in the past 90 days.Read more about Avanos Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-11.32% Earnings GrowthEarnings for Avanos Medical are expected to decrease by -11.32% in the coming year, from $1.06 to $0.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -15.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -15.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for AVNS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. News and Social Media1.4 / 5News SentimentN/A News SentimentAvanos Medical has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.MarketBeat FollowsOnly 1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by Insiders2.33% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVNS Stock News HeadlinesHead-To-Head Contrast: Beta Bionics (NASDAQ:BBNX) versus Avanos Medical (NYSE:AVNS)September 21, 2026 | americanbankingnews.comSterlington Advises Avanos Medical Management Team on $1.27 Billion AcquisitionJuly 29, 2026 | businesswire.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.September 28 at 1:00 AM | Stansberry Research (Ad)Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial PartnersJuly 22, 2026 | prnewswire.comAvanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending MergerJuly 2, 2026 | prnewswire.comAvanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNSJune 24, 2026 | businesswire.comA Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price SurgeJune 4, 2026 | finance.yahoo.comAvanos Medical, Inc. Announces First Quarter 2026 ResultsMay 5, 2026 | prnewswire.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $11.23 on January 1st, 2026. Since then, AVNS stock has increased by 122.5% and is now trading at $24.99. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings results on Tuesday, May, 5th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.06. The company's quarterly revenue was up 8.8% on a year-over-year basis. Who are Avanos Medical's major shareholders? Top institutional shareholders of Avanos Medical include BlackRock Inc. (15.94%), State Street Corp (4.29%), Polar Asset Management Partners Inc. (1.60%) and Pentwater Capital Management LP (1.60%). Insiders that own company stock include Michael Greiner, Gary Blackford, Kerr Holbrook and Julie Ann Shimer. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA). Company Calendar Last Earnings5/05/2026Today9/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (12m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 AVNS's financial health is in the Green zone, according to TradeSmith. AVNS has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees4,040Year Founded2014Profitability EPS (Trailing Twelve Months)($1.61) Trailing P/E RatioN/A Forward P/E Ratio23.58 P/E GrowthN/ANet Income-$72.90 million Net Margins-10.39% Pretax Margin-9.54% Return on Equity5.39% Return on Assets3.97% Debt Debt-to-Equity Ratio0.11 Current Ratio2.48 Quick Ratio1.40 Sales & Book Value Annual Sales$715.90 million Price / Sales1.64 Cash Flow$3.42 per share Price / Cash Flow7.30 Book Value$16.73 per share Price / Book1.49Miscellaneous Outstanding Shares46,848,000Free Float45,756,000Market Cap$1.17 billion OptionableOptionable Beta1.57 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:AVNS) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSMX: From Under-the-Radar to Must-Watch!SMX (Security Matters) PLC embeds molecular-level markers directly into materials, creating a Digital Material...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
